{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "α-synuclein",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "α-synuclein A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PD involves dopaminergic neuron loss and Lewy bodies with α-synuclein aggregation.",
          "judgment": "Yes",
          "reasoning": "Aggregation is central to PD pathology."
        },
        {
          "step_name": "Step 2: Evaluate applicability of assay classes",
          "extracted_paper_info": "In vitro aggregation studies model the disease mechanism.",
          "judgment": "Yes",
          "reasoning": "Assay reflects key pathological feature."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "A53T promotes α-synuclein aggregation, indicating pathogenicity with supporting evidence."
    },
    {
      "variant_id": {
        "Gene": "α-synuclein",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "α-synuclein A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Aggregation is central to PD.",
          "judgment": "Yes",
          "reasoning": "A30P contributes to aggregation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of assay classes",
          "extracted_paper_info": "In vitro assays model the mechanism.",
          "judgment": "Yes",
          "reasoning": "Appropriate for studying aggregation."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "A30P promotes α-synuclein aggregation, indicating pathogenicity with supporting evidence."
    },
    {
      "variant_id": {
        "Gene": "α-synuclein",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "α-synuclein E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Aggregation is key in PD.",
          "judgment": "Yes",
          "reasoning": "E46K leads to aggregation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of assay classes",
          "extracted_paper_info": "In vitro studies are applicable.",
          "judgment": "Yes",
          "reasoning": "Models the disease mechanism effectively."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "E46K promotes α-synuclein aggregation, indicating pathogenicity with supporting evidence."
    }
  ]
}